Related Experiment Video
Updated: Jan 9, 2026

Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
Published on: May 2, 2025
Unplanned Hospitalization Due to All-Cause Morbidity and Its Real-World Management Practices in Patients With Fontan
Hideo Ohuchi1, Kohta Takei2, Jun Muneuchi3
1Department of Pediatric Cardiology and Adult Congenital Heart Disease Center National Cerebral and Cardiovascular Center Suita Japan.
Insights
Unplanned hospitalizations (UPH) in Fontan circulation patients are common, often due to heart failure or protein-losing enteropathy. In-hospital management strategies significantly impact readmission risk, necessitating further research for standardized care.
Area of Science:
- Cardiology
- Pediatric Cardiology
- Congenital Heart Disease Management
Background:
- Unplanned hospitalizations (UPH) management in Fontan circulation patients lacks characterization.
- Understanding UPH drivers and outcomes is crucial for this complex patient group.
Purpose of the Study:
- To characterize unplanned hospitalizations (UPH) in Fontan patients.
- To identify associations between in-hospital management and post-discharge outcomes.
Main Methods:
- Prospective follow-up of 3226 Fontan patients over 3 years.
- Analysis of UPH causes, in-hospital treatments, and readmission data.
Main Results:
- 243 UPHs occurred, with heart failure, protein-losing enteropathy, and hemorrhage as primary Fontan-related causes.
- Readmissions were frequent, driven by protein-losing enteropathy, heart failure, and hemorrhage.
- In-hospital interventions like oxygen therapy, surgery, and diuretic adjustment correlated with readmission risk.
Conclusions:
- Real-world UPH practices in Fontan patients were elucidated.
- Specific in-hospital treatments are linked to readmission risk.
- Further research is needed to establish causal links for standardized management strategies.
Background:
Management strategies of unplanned hospitalizations (UPH) vary and have not been well characterized in patients with Fontan circulation.
Methods:
We prospectively followed 3226 Fontan patients for 3 years to characterize the current UPH status and elucidate the associations between in-hospital management strategies and postdischarge outcomes.
Results:
A total of 243 UPHs occurred (2.5 cases/100 person-years). Fontan-related UPHs accounted for 154 cases (63%), most commonly due to heart failure (19%), protein-losing enteropathy (16%), hemorrhage (14%), arrhythmia (9%), thromboembolism (3%), and plastic bronchitis (2%). Fontan-unrelated UPHs (89 cases; 37%) were mainly due to infections (19%). Adult patients were more frequently hospitalized for hemorrhage and thromboembolism (P<0.05). The longest length of hospital stay was observed in protein-losing enteropathy, followed by thromboembolism and heart failure. Among nonpharmacological treatments, oxygen therapy was commonly used, followed by surgical procedures and catheter-based interventions. Among pharmacological treatments, diuretics were commonly administered, followed by heparin and catecholamines. Of 240 patients discharged alive, 76 (15.4 cases/100 person-years) were readmitted. Protein-losing enteropathy was the most frequent cause of readmission, followed by heart failure and hemorrhage. In addition to conventional risk factors, in-hospital management practices, such as oxygen therapy, surgical intervention, and diuretic adjustment were associated with readmission risk (P<0.01-0.001).
Conclusions:
We clarified real-world practices related to UPHs in Fontan patients. Specific in-hospital treatment strategies were associated with the risk of readmission. Further studies are warranted to determine the causal relationships between treatment approaches and outcomes for standardized management strategies.
More Related Videos
Related Concept Videos
Heart Failure V: Medical Management
Aortic Regurgitation IV: Nursing Management
Mitral Stenosis IV: Nursing Management
Mitral Regurgitation IV: Nursing Management
Cardiomyopathy VI: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management

